These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29170735)

  • 21. Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds.
    Qu M; Xu H; Li W; Chen J; Zhang Y; Xu B; Li Z; Liu T; Guo L; Xie J
    Arch Toxicol; 2021 Nov; 95(11):3559-3573. PubMed ID: 34510228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicotoXilico: An Interactive Database to Predict Mutagenicity, Genotoxicity, and Carcinogenicity of Mycotoxins.
    Tolosa J; Serrano Candelas E; Vallés Pardo JL; Goya A; Moncho S; Gozalbes R; Palomino Schätzlein M
    Toxins (Basel); 2023 May; 15(6):. PubMed ID: 37368656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose-response data: Margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose-response data.
    Chepelev N; Long AS; Beal M; Barton-Maclaren T; Johnson G; Dearfield KL; Roberts DJ; van Benthem J; White P
    Environ Mol Mutagen; 2023 Jan; 64(1):4-15. PubMed ID: 36345771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the genotoxicity of marketed pharmaceuticals.
    Snyder RD; Green JW
    Mutat Res; 2001 May; 488(2):151-69. PubMed ID: 11344042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals.
    Van Deun K; Van Cauteren H; Vandenberghe J; Canning M; Vanparys P; Coussement W
    Adverse Drug React Toxicol Rev; 1997 Nov; 16(4):215-33. PubMed ID: 9608857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ability of plant genotoxicity assays to predict carcinogenicity.
    Ennever FK; Andreano G; Rosenkranz HS
    Mutat Res; 1988; 205(1-4):99-105. PubMed ID: 3285201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolites.
    Galloway SM
    Environ Mol Mutagen; 2017 Jun; 58(5):296-324. PubMed ID: 28299826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-vinyl compounds: studies on metabolism, genotoxicity, carcinogenicity.
    Oesch F; Honarvar N; Fabian E; Berger FI; Landsiedel R
    Arch Toxicol; 2021 Oct; 95(10):3143-3159. PubMed ID: 34091723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans.
    Ennever FK; Noonan TJ; Rosenkranz HS
    Mutagenesis; 1987 Mar; 2(2):73-8. PubMed ID: 3331705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EURL ECVAM Genotoxicity and Carcinogenicity Database of Substances Eliciting Negative Results in the Ames Test: Construction of the Database.
    Madia F; Kirkland D; Morita T; White P; Asturiol D; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2020; 854-855():503199. PubMed ID: 32660827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity.
    Snyder RD
    Environ Mol Mutagen; 2009 Jul; 50(6):435-50. PubMed ID: 19334052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact.
    Müller L; Kikuchi Y; Probst G; Schechtman L; Shimada H; Sofuni T; Tweats D
    Mutat Res; 1999 May; 436(3):195-225. PubMed ID: 10354523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in in vivo genotoxicity testing: prediction of carcinogenic potential using comet and micronucleus assay in animal models.
    Kang SH; Kwon JY; Lee JK; Seo YR
    J Cancer Prev; 2013 Dec; 18(4):277-88. PubMed ID: 25337557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating publicly available information to screen potential candidates for chemical prioritization under the Toxic Substances Control Act: A proof of concept case study using genotoxicity and carcinogenicity.
    Patlewicz G; Dean JL; Gibbons CF; Judson RS; Keshava N; Vegosen L; Martin TM; Pradeep P; Simha A; Warren SH; Gwinn MR; DeMarini DM
    Comput Toxicol; 2021 Nov; 20():1-100185. PubMed ID: 35128218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity.
    Rieswijk L; Brauers KJ; Coonen ML; Jennen DG; van Breda SG; Kleinjans JC
    Mutagenesis; 2016 Sep; 31(5):603-15. PubMed ID: 27338304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.